This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, Yale University. Active years: 2022-2026.
Company Filing History:
2 out of 5,633 
2 out of 1,365 
Years Active: 2022-2026
Title: Rosanna Lau: Innovator in Hormonal Therapy Research
Introduction
Rosanna Lau is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of hormonal therapy, particularly in relation to breast cancer treatment. With a total of 2 patents, her work focuses on improving the sensitivity of tumors to endocrine therapy.
Latest Patents
Lau's latest patents include innovative methods for determining tumoral sensitivity to hormonal therapy. One of her patents introduces the sensitivity to endocrine therapy index (SETindex), which assesses estrogen receptor (ER) and progesterone receptor (PR)-related genes. This method allows for a more accurate determination of breast cancer patients' sensitivity to endocrine therapy. Another patent presents the SETER/PR index, which similarly evaluates the proportion of ER gene (ESR1) RNA transcripts containing mutations. Both patents aim to enhance treatment strategies for patients identified as sensitive to endocrine therapy.
Career Highlights
Throughout her career, Rosanna Lau has worked with esteemed institutions such as the University of Texas System and Yale University. Her research has been pivotal in advancing the understanding of hormonal therapies and their effectiveness in treating breast cancer.
Collaborations
Lau has collaborated with notable colleagues, including Bruno Sinn and Chunxiao Fu. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Rosanna Lau's work in hormonal therapy research exemplifies her commitment to improving breast cancer treatment. Her patents reflect her innovative approach and dedication to advancing medical science.